In The Face of Growing Litigation, Xarelto Makers Seek New Customers

by KJ McElrath | Mar 23, 2017 | Xarelto |

Bayer Healthcare and Janssen Pharmaceuticals, manufacturers of the anti-coagulant Xarelto...

Bayer and Janssen Call Off Clinical Trial for Xarelto – Apparently, They Don’t Think it’s Needed Anymore

by KJ McElrath | Feb 8, 2017 | Xarelto |

The most recent clinical study of Xarelto (rivaroxaban) has been halted more than a year early,...

Xarelto Lawsuits Pass the 15,000 Mark – Meanwhile, an Antidote is Still On Hold

by KJ McElrath | Dec 29, 2016 | Xarelto |

As of mid-December 2016, Janssen Pharmaceuticals is facing more than 15,000 lawsuits (most of...

Did A Faulty Blood Monitor Affect The Outcome of the Xarelto Clinical Trial?

by KJ McElrath | Dec 6, 2016 | Xarelto |

Recently, the British Medical Journal (BMJ) published a report regarding a clinical trial that...

FDA Delays Approval of Xarelto Antidote

by KJ McElrath | Aug 26, 2016 | Xarelto |

As the number of lawsuits against Xarelto manufacturer Bayer approaches 7,000, the company has...

FDA Ignores Faulty Data in Approving Xarelto

by KJ McElrath | Feb 5, 2016 | Xarelto |

For some time, there have been serious questions about the ROCKET-AF trial, the clinical study of...